Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Vitro Diagnostics (VODG) had Normalized Pre-Tax Income of $-8.54M for the most recently reported fiscal quarter, ending 2026-07-31.
| Income Statement Financials | |
$0.57M |
|
$-8.89M |
|
$0.14M |
|
$0.43M |
|
$1.83M |
|
$-1.26M |
|
$-7.29M |
|
$-8.54M |
|
|
Normalized Pre-Tax Income |
$-8.54M |
$-8.54M |
|
$-8.54M |
|
$-8.54M |
|
$-8.54M |
|
$-1.26M |
|
$-1.12M |
|
5.90M |
|
5.90M |
|
$-1.51 |
|
$-1.51 |
|
| Balance Sheet Financials | |
$6.17M |
|
$0.17M |
|
$4.08M |
|
$10.25M |
|
$3.48M |
|
$1.99M |
|
$29.87M |
|
$33.35M |
|
$-23.10M |
|
$-26.75M |
|
$-23.10M |
|
4.52M |
|
| Cash Flow Statement Financials | |
$-3.44M |
|
$-0.18M |
|
$8.74M |
|
$0.60M |
|
$5.74M |
|
$5.13M |
|
$0.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.77 |
|
-- |
|
-- |
|
-0.09 |
|
-0.09 |
|
74.65% |
|
-220.54% |
|
-220.54% |
|
-- |
|
-1497.68% |
|
-1558.68% |
|
$-3.60M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.49 |
|
6.22 |
|
14.46 |
|
36.98% |
|
31.94% |
|
-83.35% |
|
40.46% |
|
$-5.11 |
|
$-0.61 |
|
$-0.58 |
|